Literature DB >> 29113852

Tumour stem cells in meningioma: A review.

Ganeshwaran Shivapathasundram1, Agadha C Wickremesekera1, Swee T Tan2, Tinte Itinteang3.   

Abstract

Meningioma is a common intracranial and intraspinal neoplasm accounting for 25-30% of all primary neurological tumours. It is associated with high rates of recurrence especially in higher-grade tumours and lesions located at the skull base. Cancer stem cells are increasingly recognised as the origin of cancer and are attributed to loco-regional recurrence, metastasis and treatment resistance. This review presents the accumulating evidence of the presence of tumour stem cells within meningioma and the stem cell markers being used to characterise this putative primitive population within this common tumour.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Embryonic; Hierarchy; Meningioma; Primitive population; Stem cells

Mesh：

Substances：

Year:  2017        PMID： 29113852     DOI： 10.1016/j.jocn.2017.10.059

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN： 0967-5868            Impact factor:   1.961


  7 in total

1.  Characterization and comparison of genomic profiles between primary cancer cell lines and parent atypical meningioma tumors.

Authors:  Eunhye Kim; Mirae Kim; Kyungha So; Young Seok Park; Chang Gok Woo; Sang-Hwan Hyun
Journal:  Cancer Cell Int       Date:  2020-07-28       Impact factor: 5.722

2.  In situ characterization of stem cells-like biomarkers in meningiomas.

Authors:  Hanin Alamir; Mona Alomari; Abdulla Ahmed A Salwati; Mohamad Saka; Mohammed Bangash; Saleh Baeesa; Fahad Alghamdi; Angel Carracedo; Hans-Juergen Schulten; Adeel Chaudhary; Adel Abuzenadah; Deema Hussein
Journal:  Cancer Cell Int       Date:  2018-05-25       Impact factor: 5.722

3.  Expression of Embryonic Stem Cell Markers on the Microvessels of WHO Grade I Meningioma.

Authors:  Ganeshwaran Shivapathasundram; Agadha C Wickremesekera; Helen D Brasch; Reginald Marsh; Swee T Tan; Tinte Itinteang
Journal:  Front Surg       Date:  2018-10-26

4.  Array expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas.

Authors:  Hans-Juergen Schulten; Deema Hussein
Journal:  PLoS One       Date:  2019-05-13       Impact factor: 3.240

Review 5.  Receptor Tyrosine Kinases as Candidate Prognostic Biomarkers and Therapeutic Targets in Meningioma.

Authors:  Rafael Roesler; Barbara Kunzler Souza; Gustavo R Isolan
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

6.  Dissecting Stemness in Aggressive Intracranial Meningiomas: Prognostic Role of SOX2 Expression.

Authors:  Rina Di Bonaventura; Maurizio Martini; Tonia Cenci; Valerio Maria Caccavella; Valeria Barresi; Marco Gessi; Alessio Albanese; Liverana Lauretti; Roberto Pallini; Quintino Giorgio D'Alessandris; Alessandro Olivi
Journal:  Int J Mol Sci       Date:  2022-10-02       Impact factor: 6.208

Review 7.  Repurposing of Anticancer Stem Cell Drugs in Brain Tumors.

Authors:  Hisham F Bahmad; Darine Daher; Abed A Aljamal; Mohamad K Elajami; Kei Shing Oh; Juan Carlos Alvarez Moreno; Ruben Delgado; Richard Suarez; Ana Zaldivar; Roshanak Azimi; Amilcar Castellano; Robert Sackstein; Robert J Poppiti
Journal:  J Histochem Cytochem       Date:  2021-06-24       Impact factor: 2.479
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.